<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">1254142</journal-id>
<journal-id journal-id-type="pubmed-jr-id">6777</journal-id>
<journal-id journal-id-type="nlm-ta">Psychol Med</journal-id>
<journal-id journal-id-type="iso-abbrev">Psychol Med</journal-id>
<journal-title-group>
<journal-title>Psychological medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">0033-2917</issn>
<issn pub-type="epub">1469-8978</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27995817</article-id>
<article-id pub-id-type="pmc">5352523</article-id>
<article-id pub-id-type="doi">10.1017/S0033291716003184</article-id>
<article-id pub-id-type="manuscript">NIHMS836272</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Psychophysiological endophenotypes to characterize mechanisms of known schizophrenia genetic loci</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Malone</surname>
<given-names>S. M.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vaidyanathan</surname>
<given-names>U.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Keller</surname>
<given-names>M. C.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McGue</surname>
<given-names>M.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Iacono</surname>
<given-names>W. G.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vrieze</surname>
<given-names>S. I.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Institute for Behavioral Genetics, University of Colorado Boulder, Boulder, CO, USA</aff>
<aff id="A2"><label>2</label>Department of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO, USA</aff>
<aff id="A3"><label>3</label>Department of Psychology, University of Minnesota, Minneapolis, MN, USA</aff>
<aff id="A4"><label>4</label>National Institutes of Health, Bethesda, MD, USA</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Address for correspondence: S. I. Vrieze, Ph.D., Institute for Behavioral Genetics, University of Colorado Boulder, 1480 30th Street, Boulder, CO 80303, USA. (<email>scott.vrieze@colorado.edu</email>)</corresp>
<fn fn-type="COI-statement" id="FN3">
<p>
<bold>Declaration of Interest</bold>
</p>
<p>None.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>15</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>20</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>4</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>4</month>
<year>2018</year>
</pub-date>
<volume>47</volume>
<issue>6</issue>
<fpage>1116</fpage>
<lpage>1125</lpage>
<!--elocation-id from pubmed: 10.1017/S0033291716003184-->
<abstract>
<sec id="S1">
<title>Background</title>
<p id="P1">Endophenotypes are laboratory-based measures hypothesized to lie in the causal chain between genes and clinical disorder, and to serve as a more powerful way to identify genes associated with the disorder. One promise of endophenotypes is that they may assist in elucidating the neurobehavioral mechanisms by which an associated genetic polymorphism affects disorder risk in complex traits. We evaluated this promise by testing the extent to which variants discovered to be associated with schizophrenia through large-scale meta-analysis show associations with psychophysiological endophenotypes.</p>
</sec>
<sec id="S2">
<title>Method</title>
<p id="P2">We genome-wide genotyped and imputed 4905 individuals. Of these, 1837 were whole-genome-sequenced at 11Ã— depth. In a community-based sample, we conducted targeted tests of variants within schizophrenia-associated loci, as well as genome-wide polygenic tests of association, with 17 psychophysiological endophenotypes including acoustic startle response and affective startle modulation, antisaccade, multiple frequencies of resting electroencephalogram, electrodermal activity and P300 event-related potential.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P3">Using single variant tests and gene-based tests we found suggestive evidence for an association between contactin 4 (<italic>CNTN4</italic>) and antisaccade and P300. We were unable to find any other variant or gene within the 108 schizophrenia loci significantly associated with any of our 17 endophenotypes. Polygenic risk scores indexing genetic vulnerability to schizophrenia were not related to any of the psychophysiological endophenotypes after correction for multiple testing.</p>
</sec>
<sec id="S4">
<title>Conclusions</title>
<p id="P4">The results indicate significant difficulty in using psychophysiological endophenotypes to characterize the genetically influenced neurobehavioral mechanisms by which genome-wide association study-identified risk loci affect disorder risk.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Endophenotypes</kwd>
<kwd>gene-based tests</kwd>
<kwd>polygenic risk scores</kwd>
<kwd>schizophrenia</kwd>
<kwd>single variant association</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>